Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TP53 | P04637 | 1/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.43 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 3/20 | 0.34 |
| ▸ | PKM | P14618 | 1/20 | 0.34 |
| ▸ | HPGD | P15428 | 1/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.33 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.33 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.33 |
| ▸ | ALOX5 | P09917 | 2/20 | 0.32 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.32 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.32 |
| ▸ | NPC1 | O15118 | 2/20 | 0.32 |
| ▸ | RAB9A | P51151 | 2/20 | 0.32 |
| ▸ | ESR1 | P03372 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30573080 | 1.00 | TP53 (0.45) | TP53TDP1ALDH1A1TRPA1MAPT | |
| SCHEMBL5940996 | 0.84 | TDP1 (0.46) | TP53TDP1ALDH1A1TRPA1MAPT | |
| SCHEMBL10871325 | 0.79 | ALDH1A1 (0.50) | ALDH1A1MAPTPKMCYP1A2CYP3A4 | |
| SCHEMBL2788648 | 0.78 | ALDH1A1 (0.50) | TP53TDP1ALDH1A1TRPA1MAPT | |
| SCHEMBL29407001 | 0.78 | ALDH1A1 (0.50) | TP53TDP1ALDH1A1TRPA1MAPT | |
| SCHEMBL293173 | 0.78 | ALDH1A1 (0.50) | TP53TDP1ALDH1A1TRPA1MAPT | |
| SCHEMBL215089 | 0.78 | TP53 (0.38) | TP53TDP1ALDH1A1TRPA1MAPT | |
| SCHEMBL16950606 | 0.77 | ALDH1A1 (0.42) | ALDH1A1MAPTPKMCYP1A2CYP3A4 | |
| SCHEMBL3432665 | 0.77 | TDP1 (0.50) | TP53TDP1ALDH1A1TRPA1MAPT | |
| SCHEMBL1788343 | 0.77 | ALDH1A1 (0.49) | TDP1ALDH1A1MAPTHPGDTSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250388541-A1 | HETEROARYL COMPOUNDS FOR THE TREATMENT OF PAIN | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2025-12-25 | — | — | US | disclosed |
| US-20250145629-A1 | ION CHANNEL MODULATORS | PRAXIS PRECISION MEDICINES, INC. | 2025-05-08 | — | — | US | disclosed |
| EP-4511117-A1 | HETEROARYL COMPOUNDS FOR THE TREATMENT OF PAIN | Vertex Pharmaceuticals Incorporated (US) | 2025-02-26 | — | — | EP | disclosed |
| EP-4511114-A1 | HETEROARYL COMPOUNDS FOR THE TREATMENT OF PAIN | Vertex Pharmaceuticals Incorporated (US) | 2025-02-26 | — | — | EP | disclosed |
| US-12145939-B2 | Substituted [1,2,4]triazolo[4,3-a]pyrazines as ion channel modulators | PRAXIS PRECISION MEDICINES, INC. (US) | 2024-11-19 | — | — | US | disclosed |
| US-20240043433-A1 | ION CHANNEL MODULATORS | PRAXIS PRECISION MEDICINES, INC. | 2024-02-08 | — | — | US | disclosed |
| US-20230382910-A1 | HETEROARYL COMPOUNDS FOR THE TREATMENT OF PAIN | VERTEX PHARMACEUTICALS INCORPORATED | 2023-11-30 | — | — | US | disclosed |
| US-20230382910-A1 | HETEROARYL COMPOUNDS FOR THE TREATMENT OF PAIN | VERTEX PHARMACEUTICALS INCORPORATED | 2023-11-30 | — | — | US | disclosed |
| US-20230382910-A1 | HETEROARYL COMPOUNDS FOR THE TREATMENT OF PAIN | VERTEX PHARMACEUTICALS INCORPORATED | 2023-11-30 | — | — | US | disclosed |
| WO-2023205465-A1 | HETEROARYL COMPOUNDS FOR THE TREATMENT OF PAIN | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2023-10-26 | — | — | WO | disclosed |
| US-4994515-A | Resin of styrene and unsaturated imide, high impact thermoplastic, bromine-containing reaction product, silicon resin or compound | SHOWA DENKO KABUSHIKI KAISHA (JP) | 1991-02-19 | — | — | US | disclosed |
| EP-0245475-B1 | CATIONIC POLYMERIZATION OF BROMOALKENYL AROMATIC COMPOUNDS WITH AROMATIC CHAIN TRANSFER AGENT, AND PRODUCTS | GENERAL ELECTRIC COMPANY (US) | 1990-10-24 | — | — | EP | disclosed |
| EP-0348906-A1 | Heat-resistant resin composition | SHOWA DENKO KABUSHIKI KAISHA (JP) | 1990-01-03 | — | — | EP | disclosed |
| US-4755573-A | Cationic polymerization of bromoalkenyl aromatic compounds with aromatic chain transfer agent, and products | GENERAL ELECTRIC COMPANY (US) | 1988-07-05 | — | — | US | disclosed |
| EP-0245475-A4 | CATIONIC POLYMERIZATION OF BROMOALKENYL AROMATIC COMPOUNDS WITH AROMATIC CHAIN TRANSFER AGENT, AND PRODUCTS. | GEN ELECTRIC (US) | 1988-03-30 | — | — | EP | disclosed |
| EP-0245475-A1 | CATIONIC POLYMERIZATION OF BROMOALKENYL AROMATIC COMPOUNDS WITH AROMATIC CHAIN TRANSFER AGENT, AND PRODUCTS. | GEN ELECTRIC (US) | 1987-11-19 | — | — | EP | disclosed |
| WO-1987002998-A1 | CATIONIC POLYMERIZATION OF BROMOALKENYL AROMATIC COMPOUNDS WITH AROMATIC CHAIN TRANSFER AGENT, AND PRODUCTS | GENERAL ELECTRIC COMPANY (US) | 1987-05-21 | — | — | WO | disclosed |
| EP-0082252-B1 | PROCESS FOR PRODUCING FLUORINE-CONTAINING ORGANIC COMPOUND | Daikin Kogyo Co., Ltd. (JP) | 1985-08-21 | — | — | EP | disclosed |
| US-4484993-A | ULTRASONIC ENERGY | DAIKIN KOGYO CO., LTD. (JP) | 1984-11-27 | — | — | US | disclosed |
| EP-0082252-A1 | Process for producing fluorine-containing organic compound | Daikin Kogyo Co., Ltd. (JP) | 1983-06-29 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12145939-B2 | Substituted [1,2,4]triazolo[4,3-a]pyrazines as ion channel modulators | SCN1A, SCN2A, SCN5A | TP53 4511/4885TDP1 2569/4885ALDH1A1 1576/4885 |
| US-20250388541-A1 | HETEROARYL COMPOUNDS FOR THE TREATMENT OF PAIN | SCN1B, CLIC1, HCN1 | TP53 4722/4885TDP1 3016/4885ALDH1A1 832/4885 |
| US-20250145629-A1 | ION CHANNEL MODULATORS | SCN1A, SCN3A, SCN2A | TP53 4802/4885TDP1 3478/4885ALDH1A1 1953/4885 |
| US-20240043433-A1 | ION CHANNEL MODULATORS | SCN1A, SCN3A, SCN2A | TP53 4802/4885TDP1 3478/4885ALDH1A1 1953/4885 |
| US-20230382910-A1 | HETEROARYL COMPOUNDS FOR THE TREATMENT OF PAIN | TRPV1, SCN3A, KCNN3 | TP53 4382/4885TDP1 3607/4885ALDH1A1 1762/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.